mTOR inhibitors lower an intrinsic barrier to virus infection mediated by IFITM3

Sirolimus 0301 basic medicine 0303 health sciences Multidisciplinary TOR Serine-Threonine Kinases Membrane Proteins RNA-Binding Proteins Endosomes Virus Internalization Antiviral Agents 7. Clean energy Cell Line 3. Good health Protein Transport 03 medical and health sciences HEK293 Cells PNAS Plus Virus Diseases Cell Line, Tumor Host-Pathogen Interactions Humans HeLa Cells
DOI: 10.1073/pnas.1811892115 Publication Date: 2018-10-09T15:50:07Z
ABSTRACT
SignificanceGene delivery by virus-like particles holds enormous therapeutic potential to correct inherited genetic disorders and to prevent infectious disease. However, cells express antiviral factors that prevent virus infection and, consequently, limit the success of gene therapy. Here, we reveal the mechanism by which the drug rapamycin improves lentivirus-mediated gene delivery. Rapamycin treatment led to degradation of IFITM3, a broad and potent antiviral protein which inhibits virus entry into cells. IFITM3 is selectively cleared from endosomes, the sites where viral and cellular membranes fuse, and is sorted for disposal in lysosomes. While revealing an immunosuppressive function with clinical benefits, we caution that rapamycin use in humans may facilitate infection by pathogenic viruses like Influenza A virus.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (84)
CITATIONS (75)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....